References
- Roger VL. Of Probabilities and Uncertainties: Current Challenges of the Heart Failure Epidemic. JACC Hear Fail. 2018;6(8):686–688. doi:10.1016/J.JCHF.2018.05.003
- McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368
- Han X, Zhang S, Chen Z, et al. Cardiac biomarkers of heart failure in chronic kidney disease. Clin Chim Acta. 2020;510(May):298–310. doi:10.1016/j.cca.2020.07.040
- Nagarajan V, Hernandez A V., Tang WHW. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart. 2012;98(24):1778–1786. doi:10.1136/HEARTJNL-2012-301779
- Latini R, Masson S, Anand IS, et al. Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure. Published online 2007. doi:10.1161/CIRCULATIONAHA.106.655076
- Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009;4(5):914–920. doi:10.2215/CJN.03900808
- Seliger S. The Cardiorenal Syndrome: Mechanistic Insights and Prognostication with Soluble Biomarkers. Curr Cardiol Rep. 2020;22(10). doi:10.1007/s11886-020-01360-8
- Kajimoto H, Kai H, Aoki H, et al. Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine. Kidney Int. 2012;81(8):762–768. doi:10.1038/KI.2011.476
- Amann K, Breitbach M, Ritz E, Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol. 1998;9(6):1018–1022. doi:10.1681/ASN.V961018
- Sezer S, Karakan S, Ozdemir N. Increased cardiac troponin T levels are related to inflammatory markers and various indices of renal function in chronic renal disease patients. Ren Fail. 2012;34(4):454–459. doi:10.3109/0886022X.2012.656562
- London GM. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant. 2002;17 Suppl 1(SUPPL. 1):29–36. doi:10.1093/NDT/17.SUPPL_1.29
- Bansal N, Anderson AH, Yang W, et al. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: The chronic renal insufficiency cohort (CRIC) study. J Am Soc Nephrol. 2015;26(4):946–956. doi:10.1681/ASN.2014010108
- Otsuka K, Nakanishi K, Shimada K, et al. Associations of sensitive cardiac troponin-I with left ventricular morphology, function and prognosis in end-stage renal disease patients with preserved ejection fraction. Heart Vessels. 2018;33(11):1334–1342. doi:10.1007/s00380-018-1192-7
- Kitagawa M, Sugiyama H, Morinaga H, et al. Serum high-sensitivity cardiac troponin T is a significant biomarker of left-ventricular diastolic dysfunction in subjects with non-diabetic chronic kidney disease. Nephron Extra. 2011;1(1):166–177. doi:10.1159/000333801
- Aimo A, Januzzi JL, Vergaro GGV, et al. Prognostic value of high-sensitivity troponin T in chronic heart failure an individual patient data meta-analysis. Circulation. 2018;137(3):286–297. doi:10.1161/CIRCULATIONAHA.117.031560
- DeFilippi C, Seliger SL, Kelley W, et al. Interpreting Cardiac Troponin Results from High-Sensitivity Assays in Chronic Kidney Disease without Acute Coronary Syndrome. Clin Chem. 2012;58(9):1342–1351. doi:10.1373/CLINCHEM.2012.185322
- Parikh RH, Seliger SL, deFilippi CR. Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. Clin Biochem. 2015;48(4–5):247–253. doi:10.1016/j.clinbiochem.2015.01.004
- Canney M, Tang M, Er L, Barbour SJ, Djurdjev O, Levin A. Glomerular Filtration Rate-Specific Cutoffs Can Refine the Prognostic Value of Circulating Cardiac Biomarkers in Advanced Chronic Kidney Disease. Can J Cardiol. 2019;35(9):1106–1113. doi:10.1016/j.cjca.2019.06.014
- Schoenfeld SR, Kasturi S, Costenbader KH. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review. Semin Arthritis Rheum. 2013;43(1):77–95. doi:10.1016/j.semarthrit.2012.12.002
- Masson S, Anand I, Favero C, et al. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: Data from 2 large randomized clinical trials. Circulation. 2012;125(2):280–288. doi:10.1161/CIRCULATIONAHA.111.044149
- Kawahara C, Tsutamoto T, Sakai H, et al. Prognostic value of serial measurements of highly sensitive cardiac troponin i in stable outpatients with nonischemic chronic heart failure. Am Heart J. 2011;162(4):639–645. doi:10.1016/j.ahj.2011.07.007
- Zymliński R, Sokolski M, Siwolowski P, et al. Elevated troponin I level assessed by a new high-sensitive assay and the risk of poor outcomes in patients with acute heart failure. Int J Cardiol. 2017;230:646–652. doi:10.1016/j.ijcard.2017.01.012
- Demissei BG, Cotter G, Prescott MF, et al. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial. Eur J Heart Fail. 2017;19(8):1001–1010. doi:10.1002/ejhf.749
- Ripley TL. Valsartan in chronic heart failure. Ann Pharmacother. 2005;39(3):460–469. doi:10.1345/aph.1E327
- GISSI-HF investigators. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1231–1239. doi:10.1016/S0140-6736(08)61240-4
- Aulin J, Hijazi Z, Lindbäck J, et al. Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model. Am Heart J. 2022;251:13–24. doi:10.1016/j.ahj.2022.03.009
- Berge K, Brynildsen J, Roysland R, et al. Prognostic value of cardiac biomarkers and National Early Warning Score 2 in acute dyspnoea. Open Hear. 2022;9(1):1–8. doi:10.1136/openhrt-2021-001938
- Aimo A, Januzzi JL, Mueller C, et al. Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure. Int J Cardiol. 2019;293:137–142. doi:10.1016/j.ijcard.2019.06.005
- Ledwoch J, Krauth A, Kraxenberger J, et al. Accuracy of high-sensitive troponin depending on renal function for clinical outcome prediction in patients with acute heart failure. Heart Vessels. 2022;37(1):69–76. doi:10.1007/s00380-021-01890-3
- Ledwoch J, Kraxenberger J, Krauth A, et al. Prognostic impact of high-sensitive troponin on 30-day mortality in patients with acute heart failure and different classes of left ventricular ejection fraction. Heart Vessels. 2022;37(7):1195–1202. doi:10.1007/s00380-022-02026-x
- Berge K, Lyngbakken MN, Myhre PL, et al. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study. Clin Biochem. 2021;88(October 2020):30–36. doi:10.1016/j.clinbiochem.2020.11.009
- Jungbauer CG, Riedlinger J, Block D, et al. Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure. Biomark Med. 2014;8(6):777–789. doi:10.2217/bmm.14.31
- Guisado Espartero ME, Salamanca-Bautista P, Aramburu-Bodas O, et al. Troponin T in acute heart failure: Clinical implications and prognosis in the Spanish National Registry on Heart Failure. Eur J Intern Med. 2014;25(8):739–744. doi:10.1016/j.ejim.2014.08.005
- Barlera S, Tavazzi L, Franzosi MG, et al. Predictors of mortality in 6975 patients with chronic heart failure in the gruppo italiano per lo studio della streptochinasi nell'infarto miocardico-heart failure trial proposal for a nomogram. Circ Hear Fail. 2013;6(1):31–39. doi:10.1161/CIRCHEARTFAILURE.112.967828
- Masson S, Anand C, Favero S, et al. Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure Data From 2 Large Randomized Clinical Trials. Published online 2012. doi:10.1161/CIRCULATIONAHA.111
- Lupón J, De Antonio M, Galán A, et al. Combined use of the novel biomarkers high-sensitivity troponin t and st2 for heart failure risk stratification vs conventional assessment. Mayo Clin Proc. 2013;88(3):234–243. doi:10.1016/j.mayocp.2012.09.016
- Ather S, Hira RS, Shenoy M, et al. Recurrent low-level Troponin i elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int J Cardiol. 2013;166(2):394–398. doi:10.1016/j.ijcard.2011.10.113
- Lok DJ, Klip IT, Lok SI, et al. Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure. Am J Cardiol. 2013;112(6):831–837. doi:10.1016/j.amjcard.2013.05.013
- Egstrup M, Schou M, Tuxen CD, et al. Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure. Am J Cardiol. 2012;110(4):552–557. doi:10.1016/j.amjcard.2012.04.033
- Zhang Y, Guallar E, Blasco-Colmenares E, et al. Clinical and serum-based markers are associated with death within 1 year of de novo implant in primary prevention ICD recipients. Hear Rhythm. 2015;12(2):360–366. doi:10.1016/j.hrthm.2014.10.034
- Fabbri A, Marchesini G, Carbone G, et al. Acute heart failure in the emergency department: a follow-up study. Intern Emerg Med. 2016;11(1):115–122. doi:10.1007/s11739-015-1336-z
- Lee N, Cho JY, Kim KH, et al. Impact of Cardiac Troponin Elevation on Mortality of Patients with Acute Heart Failure: Insights from the Korea Acute Heart Failure (KorAHF) Registry. J Clin Med. 2022;11(10):1–13. doi:10.3390/jcm11102800
- Bayes-Genis A, Zamora E, De Antonio M, et al. Soluble ST2 serum concentration and renal function in heart failure. J Card Fail. 2013;19(11):768–775. doi:10.1016/j.cardfail.2013.09.005
- Michael Felker G, Hasselblad V, Wilson Tang WH, et al. Troponin i in acute decompensated heart failure: Insights from the ASCEND-HF study. Eur J Heart Fail. 2012;14(11):1257–1264. doi:10.1093/eurjhf/hfs110
- McDowell K, Campbell R, Simpson J, et al. Incremental prognostic value of biomarkers in PARADIGM-HF. Eur J Heart Fail. 2023;25(8):1406–1414. doi:10.1002/ejhf.2887
- Tentzeris I, Jarai R, Farhan S, et al. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. Eur J Heart Fail. 2011;13(7):726–733. doi:10.1093/eurjhf/hfr049
- Bjurman C, Jensen J, Petzold M, et al. Assessment of a multimarker strategy for prediction of mortality in older heart failure patients: a cohort study. BMJ Open. 2013;(3). doi:10.1136/bmjopen-2012
- Yilmaz Oztekin GM, Genç A. Prognostic Significance of High-Sensitivity Troponin T in Nonischemic Heart Failure with Reduced Ejection Fraction. Turk Kardiyol Dern Ars. 2023;51(2):129–134. doi:10.5543/tkda.2023.26900
- Bosselmann H, Egstrup M, Rossing K, et al. Prognostic significance of cardiovascular biomarkers and renal dysfunction in outpatients with systolic heart failure: A long term follow-up study. Int J Cardiol. 2013;170(2):202–207. doi:10.1016/j.ijcard.2013.10.064
- HORIUCHI YU, WETTERSTEN N, VELDHUISEN DJ va., et al. Potential Utility of Cardiorenal Biomarkers for Prediction and Prognostication of Worsening Renal Function in Acute Heart Failure. J Card Fail. 2021;27(5):533–541. doi:10.1016/j.cardfail.2020.11.025
- O'Connor CM, Fiuzat M, Lombardi C, et al. Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study. Circ Hear Fail. 2011;4(6):724–732. doi:10.1161/CIRCHEARTFAILURE.111.961581
- Aimo A, Januzzi JL, Vergaro G, et al. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure. Int J Cardiol. 2019;277:166–172. doi:10.1016/j.ijcard.2018.10.079
- Mueller C, McDonald K, de Boer RA, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21(6):715–731. doi:10.1002/ejhf.1494